Pompe Disease Market Set for Expansion During the Forecast Period (2026-2036) as Growth is Fueled by Next-Generation ERTs, Newborn Screening, and Pipeline Innovation | DelveInsight
The Pompe disease market is estimated to change significantly during the forecast period (2026–2036), owing to the launch of novel therapies including MZE001 (S-606001; Shionogi and Maze Therapeutics), AT845 (Astellas Pharma), AB-1009 [AskBio (Bayer)], DNL952 (Denali Therapeutics),...